A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
- Status
- TERMINATED
- Phase
- PHASE2
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
- Status
- WITHDRAWN
- Phase
- PHASE1
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2